Annual report
9218.TEDINET S100XVL7
Period2025-01-01 → 2025-12-31
Filed2026-03-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥5.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥599m | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥110m | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥438m | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥39m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥496m | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥346m | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥136m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥424m | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥46m | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥255m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥30m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥265m | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥162m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥255m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | −¥30m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥5.4bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.3bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥664m | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥3.4bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.6bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥655m | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥247m | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥423m | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥632m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥271m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥178m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥377m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥202m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥324m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥91m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥260m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥21m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥68m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥167m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥119m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥53m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥24.56 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.92 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.29 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.19 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.12 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.09 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.78 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.13 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥131.05 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥106.15 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥110.31 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥66.63 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥25.86 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 25.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.5% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.3% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 20.7% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 49.9% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 58.8% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 132.1% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 140 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 137 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 92 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 92 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 58 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥869m | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥725m | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥568m | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥499m | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥343m | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥385m | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥29m | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥508m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥32m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥167m | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥42m | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥39m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥508m | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥23m | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥434m | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥76m | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥194m | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥36m | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥40m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.3bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.6bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥823m | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.8bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.5bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥971m | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥758m | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥579m | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥548m | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥462m | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥41.8 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.51 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.47 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.73 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.47 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.37 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥3.45 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥129.89 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥87.66 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥96.03 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥77.1 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥60.53 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 31.3% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.8% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 38.4% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.5% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,447,300 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,329,300 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,107,300 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,835,300 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,566,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 22 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 22 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 20 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 22 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 15 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | employees | at 2025-12-31 | 10 pure |
| Otherother segments | revenue | 2025-01-01 → 2025-12-31 | ¥172m |
| Otherother segments | revenue external | 2025-01-01 → 2025-12-31 | ¥112m |
| Otherother segments | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥60m |
| Otherother segments | segment profit | 2025-01-01 → 2025-12-31 | ¥119,000 |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥147m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥61m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥61m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥558m |
| Medical Work Shift Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥3m |
| Medical Work Shift Businessreportable segment | employees | at 2025-12-31 | 33 pure |
| Medical Work Shift Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥3.3bn |
| Medical Work Shift Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥3.3bn |
| Medical Work Shift Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥266m |
| Mental Health Solution Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥33m |
| Mental Health Solution Businessreportable segment | employees | at 2025-12-31 | 82 pure |
| Mental Health Solution Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥3.1bn |
| Mental Health Solution Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥3.1bn |
| Mental Health Solution Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥1m |
| Mental Health Solution Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥890m |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥36m |
| —segment total | employees | at 2025-12-31 | 125 pure |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥6.5bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥6.4bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥61m |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥1.2bn |
| Otherother segments | revenue | 2024-01-01 → 2024-12-31 | ¥216m |
| Otherother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥162m |
| Otherother segments | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥54m |
| Otherother segments | segment profit | 2024-01-01 → 2024-12-31 | ¥38m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥116m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥853m |
| Medical Work Shift Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥3m |
| Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.4bn |
| Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.4bn |
| Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥267m |
| Mental Health Solution Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥28m |
| Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥1m |
| Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥658m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥32m |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥5.2bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥5.1bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥55m |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥963m |
| Otherother segments | employees | at 2025-12-31 | 4 pure |
| Mental Health Solution Businessreportable segment | employees | at 2025-12-31 | 3 pure |
| —segment total | employees | at 2025-12-31 | 7 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,364
| Item | Context | Value | Unit |
|---|---|---|---|
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.077 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.055 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.225 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.384 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 285.51 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 41.81 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 19.62 | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.239 | |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 15 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 22 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 20 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 22 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 22 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.764 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.689 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.779 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.960 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 0.889 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 0.952 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E37508-000MentalHealthSolutionBusinessReportableSegmentMember | 82 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E37508-000MentalHealthSolutionBusinessReportableSegmentMember | 17 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E37508-000MedicalWorkShiftBusinessReportableSegmentMember | 33 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E37508-000MedicalWorkShiftBusinessReportableSegmentMember | 1123 | |
| Number of employees | CurrentYearInstant_OtherReportableSegmentsMember | 10 | |
| Average number of temporary workers | CurrentYearInstant_OtherReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_ReportableSegmentsMember | 125 | |
| Average number of temporary workers | CurrentYearInstant_ReportableSegmentsMember | 1140 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 15 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 1 | |
| Number of employees | CurrentYearInstant | 140 | |
| Average number of temporary workers | CurrentYearInstant | 1141 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 22 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 44.1 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5.9 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6656841 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37508-000MentalHealthSolutionBusinessReportableSegmentMember | 3 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_OtherReportableSegmentsMember | 4 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember | 7 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 15 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |